Brought to you by the Society of Gynecologic Surgeons.
In a recent expansion of laser technology, dozens of manufacturers have started marketing fractional ablative and non-ablative technology for gynecologic office-based procedures. This technology has been used to treat conditions such as atrophic vaginitis, vaginal laxity, lichen sclerosus, and stress urinary incontinence. In this video, the authors describe the biophysics of fractional ablative and non-ablative lasers, provide a procedural demonstration, list outcomes from available research, and discuss ethical concerns.
This video is brought to you by
Options for treating the symptoms of genitourinary syndrome of menopause are expanding. Vaginal estrogen cream, an oral nonestrogen agent (...
With many, and growing, options for managing the sexual health of your patients, how would these 5 experts manage the following common case...
With more than 1 billion menopausal women likely to be affected by vulvovaginal atrophy worldwide by 2025, the need for effective remedies is...
